Cover Image
市場調查報告書

醫療市場調查綜述:2015年

2015 Healthcare Research Review

出版商 BCC Research 商品編碼 227024
出版日期 內容資訊 英文 182 Pages
訂單完成後即時交付
價格
Back to Top
醫療市場調查綜述:2015年 2015 Healthcare Research Review
出版日期: 2016年01月11日 內容資訊: 英文 182 Pages
簡介

美國實驗室開發的檢測 (LDT:Laboratory Developed Test) 市場預估在2014年至2019年以12.7%的CAGR推移,預計將從2014年的97億美元,於2019年成長至近177億美元規模。

本報告從BBCC Research於2015年出版的報告中,挑選特定研究類別報告 (LDT、放射線治療、微創醫療設備、拋棄式醫療用感測器、健康狀態的自我監測、眼科設備),摘錄並彙整各種技術現況與開發趨勢、相關法規及其他市場影響因子分析、未來市場展望等。

第1章 前言

第2章 實驗室開發的檢測 (LDT:Laboratory Developed Test) 各種技術與市場 (REPORT HLC179A)

  • 簡介
  • 摘要
  • 主要趨勢
    • FDA法規的崛起
    • 基因體強化
    • 學術醫療中心衰退
    • LDT演進
    • 分子診斷爆發性發展
    • 轉向授權&對新興企業投資
    • 血清學逐步衰退
  • LDT概要
  • 臨床診斷測試生命週期
  • 利用LDT的理由
  • 一般技術
    • PCR
    • 次世代定序
    • 其他分子技術
    • 質量分析
    • HPLC-MS
    • MALDI-TOF
    • 免疫分析
  • 適應症
    • 傳染病
    • 罕見疾病
    • 產科
    • 慢性疾病
  • LDT與FDA審核檢測的差異

第3章 放射線治療各種技術與全球市場 (REPORT HLC176A)

  • 簡介
  • 摘要整理
  • 市場概要
  • 關於癌症
    • 良性腫瘤
    • 惡性腫瘤
    • 其他類型癌症
    • 癌症原因
    • 保護因子、風險因子
    • 關於放射線
    • 放射線治療歷史
  • 作用機制
    • 細胞生長週期
  • 放射線治療之風險管理、品質保證
    • 放射線治療市場區分
    • 推動因子、阻礙、市場機會、各種趨勢
  • 推動因子
  • 阻礙
  • 市場機會
  • 各種趨勢
    • VMAT
    • 威脅
    • 市場佔比分析
    • 各種癌症治療
    • SRS、分次立體定位放射線治療

第4章 微創醫療設備市場 (REPORT HLC051G)

  • 微創手術
  • 簡介
  • 摘要整理
  • 一般概要
  • HISTORY OF 微創手術
    • 內視鏡
    • 注氣
    • 特殊外科器具
    • 微創手術步驟
    • 手術用機器人
    • 醫療用雷射
    • 外科各種趨勢、微創手術重要性日益增加
    • 微創手術主要對像
    • 胃腸道手術
    • 婦科
    • 泌尿科
    • 美容外科
    • 胸部外科
    • 心胸外科
    • 非心臟血管介入手術
    • 骨科手術
  • 產品類型
    • 監控/可視化裝置
    • 機器人輔助手術系統
    • 電氣手術器具
    • 機械器具
    • 輔助設備
    • 手術器材
    • MIS用器具的法規定位
    • 醫學院校

第5章 拋棄式醫療用感測器各種技術與全球市場 (REPORT HLC182A)

  • 簡介
  • 摘要整理
  • 市場概要
  • 感測器各類型
  • 市場區分
    • 主要市場趨勢
  • 市場動態
    • 推動因子
    • 阻礙
    • 市場機會
  • 市場策略
    • 對R&D的投資擴大
    • 競爭環境
  • 法規
    • 美國
    • EU
    • 中國
  • 技術創新
    • 紋身感測器
    • 貼片感測器
    • SLEEP STRIP
    • 癌症追蹤置入式感測器
    • 拋棄式HBA1C感測器
    • MEMS壓力感應器
    • NEMS:未來的技術
    • 創新的拋棄式感測器
  • 目前趨勢
  • 拋棄式無線感測器製造商的優點
  • 拋棄式醫療用感測器市場的成長預測

第6章 健康狀態的自我監測:各種技術和全球市場 (REPORT HLC185A)

  • 簡介
  • 摘要整理
  • 定義
    • 數位 VS. 類比監測技術
    • 行動 VS. 可攜式監測技術
    • 自我檢驗 VS. 自我監測
    • 健康狀態 VS. 運動&健身監測
  • 實現技術
    • 智慧型手機
    • 強化型資料處理能力
    • 感測器
    • 地理空間追蹤
    • 穿戴式感測器的智慧紡織品
    • 網路技術
    • 雲端服務
  • 市場區分
    • 技術
    • 用途
    • 購買者、支付者
    • 市場摘要

第7章 眼科設備各種技術與全球市場 (REPORT HLC173A)

  • 簡介
  • 摘要
  • 關於人眼
  • 眼部症狀、對像人口
    • 白內障
    • 青光眼
    • 糖尿病性視網膜病變
    • 老年性黃斑部病變
    • 屈光異常

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC068F

REPORT HIGHLIGHTS

  • The laboratory-developed test market within the U.S. is expected to grow from $9.7 billion in 2014 to nearly $17.7 billion in 2019, a compound annual growth rate (CAGR) of 12.7% from 2014 to 2019.
  • The radiation therapy market totaled $5.8 billion in 2014 and is expected to reach $8.1 billion in 2019, with a CAGR of 6.7%.
  • The global market for minimally invasive medical devices and equipment reached roughly $15.4 billion in 2014 and is expected to reach $21.5 billion in 2019, registering a CAGR of 6.8% for the period 2014-2019.

REPORT SCOPE

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2015, and are an efficient way for market professionals to keep up with the general market developments of 2015.

Please note that page references in the text are to pages in the original, complete report, and do not reflect the actual page numbers in this Research Review.

Table of Contents

CHAPTER 1 - FOREWORD

CHAPTER 2 - LABORATORY-DEVELOPED TESTING: TECHNOLOGIES AND MARKETS (REPORT HLC179A)

  • INTRODUCTION
    • STUDY GOALS AND OBJECTIVES
    • REASONS FOR DOING THE STUDY
    • SCOPE OF REPORT
    • INTENDED AUDIENCE
    • INFORMATION SOURCES
    • ANALYST'S CREDENTIALS
    • RELATED BCC RESEARCH REPORTS
  • SUMMARY
    • TABLE 1 MARKET FOR U.S. LABORATORY-DEVELOPED TESTS, THROUGH 2019 ($ MILLIONS)
    • FIGURE 1 MARKET FOR U.S. LABORATORY-DEVELOPED TESTS, 2012-2019 ($ MILLIONS)
  • KEY TRENDS
    • THE RISE OF FDA REGULATION
    • GENOMIC RAMP-UP
    • DECLINE OF THE ACADEMIC MEDICAL CENTER
    • EVOLUTION OF THE LABORATORY-DEVELOPED TEST (LDT)
    • MOLECULAR DIAGNOSTICS EXPLOSION
    • SHIFTS TOWARD LICENSING AND STARTUP INVESTMENT
    • SLOW DECLINE OF SEROLOGY
  • OVERVIEW: DESCRIPTION OF LABORATORY-DEVELOPED TESTS
  • LIFE CYCLE OF CLINICAL DIAGNOSTIC TESTS
    • TABLE 2 LIFE CYCLE OF CLINICAL DIAGNOSTIC TESTS
  • WHY USE AN LDT
  • COMMON TECHNOLOGIES USED
    • POLYMERASE CHAIN REACTION (PCR)
      • How PCR Works in an LDT
    • NEXT-GENERATION SEQUENCING
      • How NGS Works in LDTs
        • Sequencing by Synthesis
        • Solid Sequencing
        • Semiconductor Sequencing
    • OTHER MOLECULAR TECHNOLOGIES
    • MASS SPECTROMETRY
      • How Mass Spectrophotometry Works in LDTs
    • HPLC-MS
    • MALDI-TOF
    • IMMUNOASSAYS
      • How an Immunoassay Works in an LDT
  • CLINICAL INDICATIONS
    • ONCOLOGY
    • INFECTIOUS DISEASE
    • RARE DISEASES
    • MATERNITY
    • CHRONIC DISEASE
  • DIFFERENCES BETWEEN LDTS AND FDA APPROVED TESTS

CHAPTER 3 - RADIOTHERAPY: TECHNOLOGIES AND GLOBAL MARKETS (REPORT HLC176A)

  • INTRODUCTION
    • STUDY GOALS AND OBJECTIVES
    • REASONS FOR DOING THE STUDY
    • SCOPE OF REPORT
    • INTENDED AUDIENCE
    • RESEARCH METHODOLOGY
    • ANALYST'S CREDENTIALS
    • RELATED BCC RESEARCH REPORTS
  • EXECUTIVE SUMMARY
    • TABLE 3 RADIATION THERAPY MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 2 RADIATION THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • MARKET OVERVIEW
  • INTRODUCTION TO CANCER
    • BENIGN TUMORS
    • MALIGNANT TUMORS
      • Malignant Tumor Categories
        • Carcinomas
        • Sarcomas
    • OTHER TYPES OF CANCER
      • TABLE 4 CHARACTERISTICS OF BENIGN AND MALIGNANT TUMORS
    • CAUSES OF CANCER
      • Internal Factors
      • External Factors
    • CANCER PROTECTIVE FACTORS AND RISK FACTORS
      • TABLE 5 IMPACT OF CANCER PROTECTIVE FACTORS AND CANCER RISK FACTORS ON VARIOUS TYPES OF CANCERS
    • INTRODUCTION TO RADIATION
      • FIGURE 3 TYPES OF RADIATION
      • NON-IONIZING RADIATION
      • IONIZING RADIATION
      • PARTICLE RADIATION
        • Electron Beams
        • Proton Beams
        • Neutron Beams
        • Carbon Ions
        • Alpha and Beta Particles
        • Photon Radiations
        • Gamma Rays
        • X-rays
    • HISTORY OF RADIATION THERAPY
      • The Discovery Period
      • Megavoltage Era (1946-1996)
      • Computer-Assisted ERA (1996-2013)
  • MECHANISM OF ACTION
    • CELL GROWTH CYCLE
      • FIGURE 4 CELL GROWTH CYCLE
      • TABLE 6 STEPS INVOLVED IN RADIATION THERAPY
  • RISK MANAGEMENT AND QUALITY ASSURANCE IN RADIATION THERAPY
    • RADIATION THERAPY MARKET SEGMENTATION
      • FIGURE 5 RADIATION THERAPY MARKET SEGMENTATION
    • DRIVERS, RESTRAINTS, OPPORTUNITIES AND TRENDS
      • FIGURE 6 DRIVERS, RESTRAINTS, OPPORTUNITIES AND TRENDS IN THE RADIATION THERAPY MARKET
  • DRIVERS
    • Increasing Incidences of Cancer
    • High Incidence of Cancer in Aging Population
      • FIGURE 7 GLOBAL AGING POPULATION (MILLIONS)
      • FIGURE 8 FACTORS RELATED TO AGING AND THE PROMOTION OF CANCER
    • High Efficiency of Radiotherapy
    • Palliative Radiation Therapy
    • Government Funding
    • Advancement in Technology
    • Reimbursement Boosting Market Growth
  • RESTRAINTS
    • Capital Intensive
    • Lack of Trained Professionals
    • Limited Effectiveness against Metastatic Cancer
    • Side Effects Associated with Radiation Therapy
  • OPPORTUNITY
    • Developing Countries
    • Personalized Treatment
  • TRENDS
    • VMAT
      • Proton Therapy
      • Carbon Ions
    • THREAT
      • Recession Could Restrict the Growth of Radiation Therapy Market
    • MARKET SHARE ANALYSIS
      • FIGURE 9 MARKET SHARE ANALYSIS OF THE RADIATION THERAPY MARKET, 2013 (%)
    • VARIOUS CANCER TREATMENTS
      • TABLE 7 ADVANTAGES AND DISADVANTAGES OF VARIOUS CANCER TREATMENTS
    • STEREOTACTIC RADIOSURGERY (SRS) AND FRACTIONATED STEREOTACTIC RADIATION THERAPY

CHAPTER 4 - THE MARKET FOR MINIMALLY INVASIVE MEDICAL DEVICES (REPORT HLC051G)

  • MINIMALLY INVASIVE SURGERY
    • MINIMALLY INVASIVE SURGERY VERSUS AMBULATORY SURGERY
    • MINIMALLY INVASIVE SURGERY VERSUS NONINVASIVE SURGERY
  • INTRODUCTION
    • STUDY BACKGROUND
    • STUDY GOALS AND OBJECTIVES
    • INTENDED AUDIENCE
    • SCOPE AND FORMAT OF REPORT
    • METHODOLOGY AND INFORMATION SOURCES
    • ANALYST'S CREDENTIALS
    • RELATED BCC RESEARCH REPORTS
  • EXECUTIVE SUMMARY
    • TABLE 8 GLOBAL MARKET FOR MIS DEVICES AND EQUIPMENT, THROUGH 2019 ($ MILLIONS)
    • FIGURE 10 GLOBAL MARKET FOR MIS DEVICES AND EQUIPMENT, 2013-2019 ($ MILLIONS)
  • GENERAL DESCRIPTION
  • HISTORY OF MINIMALLY INVASIVE SURGERY
    • ENDOSCOPY
    • INSUFFLATION
    • SPECIALIZED SURGICAL INSTRUMENTS
    • MINIMALLY INVASIVE SURGICAL PROCEDURES
    • SURGICAL ROBOTICS
    • MEDICAL LASERS
    • SURGICAL TRENDS AND THE GROWING IMPORTANCE OF MINIMALLY INVASIVE SURGERY
      • FIGURE 11 MIS PROCEDURES AS A PERCENTAGE OF ALL SURGICAL PROCEDURES PERFORMED IN THE U.S., 2013 (%)
      • FIGURE 12 MIS PROCEDURES AS A PERCENTAGE OF SELECTED TYPES OF SURGICAL MEASURES IN THE U.S., 2013
    • PRINCIPAL APPLICATIONS OF MINIMALLY INVASIVE SURGERY
      • FIGURE 13 SURGICAL PROCEDURES PERFORMED IN THE U.S. USING ALL MIS APPROACHES, 2013 (% OF ALL MIS PROCEDURES)
      • TABLE 9 SURGICAL PROCEDURES COMMONLY PERFORMED IN THE U.S. USING A MINIMALLY INVASIVE APPROACH, 2013
    • GASTROINTESTINAL SURGERY
      • Gallbladder Removal (Cholecystectomy)
      • Nissen Fundoplication
      • Adhesiolysis (Removal of Abdominal Scar Tissue)
      • Gastric Bypass
      • Appendectomy
      • Colon Resection
      • Hernia Repair
    • GYNECOLOGY
      • Hysterectomy
      • Myomectomy
      • Endometrial Ablation
      • Pelvic Floor Reconstruction
      • Adnexectomy (Removal of Adnexal Structures)
    • UROLOGY
      • Nephrectomy
      • Cystocele/Rectocele Repair
      • Pediatric Urology
      • Adrenalectomy
      • Radical Prostatectomy
    • COSMETIC SURGERY
      • Breast Augmentation
      • Face and Forehead Lifts
    • THORACIC SURGERY
      • Lung Biopsy
      • Lung Resection
      • Endoscopic Thoracic Sympathectomy
    • CARDIOTHORACIC SURGERY
      • Angioplasty and Other Catheterization Types
      • Coronary Artery Bypass
      • Heart Valve Repair and Replacement
      • Congenital Heart Defect Surgery
    • NONCARDIAC VASCULAR INTERVENTIONAL SURGERY
      • Saphenous Vein Harvest
      • Peripheral Vascular Bypass
      • Aortoiliofemoral Bypass
      • Abdominal Aortic Aneurism Repair
      • Lower Extremity Angioplasty
    • ORTHOPEDIC SURGERY
      • Joint Surgery
      • Arthroscopic Surgery
      • Arthroplasty
      • Damaged or Diseased Spinal Disk Surgery
      • Microendoscopic Diskectomy
      • Intradiskal Electrothermal Annuloplasty
      • Vertebroplasty and Kyphoplasty
  • PRODUCT TYPES
    • MONITORING/VISUALIZATION EQUIPMENT
      • TABLE 10 PRINCIPAL TYPES OF MONITORING/VISUALIZATION EQUIPMENT
    • ROBOTICALLY ASSISTED SURGICAL SYSTEMS
      • TABLE 11 PRINCIPAL TYPES OF SURGICAL ROBOTIC SYSTEMS
    • ELECTROSURGICAL EQUIPMENT
      • TABLE 12 ELECTROSURGICAL EQUIPMENT
    • MECHANICAL INSTRUMENTS
      • TABLE 13 PRINCIPAL TYPES OF MECHANICAL INSTRUMENTS
    • AUXILIARY EQUIPMENT
      • TABLE 14 PRINCIPAL TYPES OF AUXILIARY EQUIPMENT USED FOR MINIMALLY INVASIVE SURGERY
    • SURGICAL DEVICES
      • TABLE 15 MINIMALLY INVASIVE SURGICAL DEVICES
    • REGULATORY STATUS OF MIS EQUIPMENT
      • UNITED STATES
      • EUROPEAN UNION (EU)
      • JAPAN
      • OTHER COUNTRIES
        • Canada
        • China
        • India
        • Latin American Nations
        • Saudi Arabia
      • END-USER SEGMENTS
      • HOSPITAL SURGICAL DEPARTMENTS
        • FIGURE 14 U.S. HOSPITALS WITH SURGERY DEPARTMENTS, 2013 (NUMBER OF HOSPITALS)
      • OUTPATIENT SURGERY CENTERS
      • GROUP PRACTICES
      • INDIVIDUAL SURGEONS
        • FIGURE 15 U.S. SURGICAL SPECIALTIES, 2013 (% OF ALL U.S. SURGEONS)
    • MEDICAL SCHOOLS

CHAPTER 5 - DISPOSABLE MEDICAL SENSORS: TECHNOLOGIES AND GLOBAL MARKETS (REPORT HLC182A)

  • INTRODUCTION
    • STUDY OBJECTIVES
    • SCOPE OF THE REPORT
    • MARKET STRUCTURE
    • INTENDED AUDIENCE
    • RESEARCH METHODOLOGY
    • ANALYST'S CREDENTIALS
    • RELATED BCC RESEARCH REPORTS
  • EXECUTIVE SUMMARY
    • TABLE 16 GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 16 GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY REGION, 2013-2019 ($ MILLIONS)
  • MARKET OVERVIEW
    • TABLE 17 EVOLUTION OF MEMS IN THE HEALTHCARE SECTOR
  • TYPES OF SENSORS
    • FIGURE 17 TYPES OF SENSORS
  • MARKET SEGMENTATION
    • KEY MARKET TRENDS
      • FIGURE 18 SEGMENTATION OF BIOSENSORS
      • FIGURE 19 GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY PRODUCT, 2013 ($ MILLIONS)
      • FIGURE 20 GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY TYPE, 2013 ($ MILLIONS)
      • FIGURE 21 GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY APPLICATION, 2013 ($ MILLIONS)
      • FIGURE 22 GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY REGION, 2013-2019 ($ MILLIONS)
  • MARKET DYNAMICS
    • DRIVERS
      • Growing Number of People Affected by Target Diseases
      • Cardiovascular Diseases
      • Cancer
        • TABLE 18 CANCER INCIDENCES, 2008 AND 2015 (MILLIONS)
      • Diabetes
        • FIGURE 23 DIABETES PREVALENCE IN TOP 10 COUNTRIES FOR AGES 20 TO YEARS, 2013 (MILLIONS)
        • FIGURE 24 GLOBAL DIABETES PREVALENCE BY REGION, 2013 AND 2035 (MILLIONS)
        • TABLE 19 NORTH AMERICA DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
        • TABLE 20 EUROPEAN DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
        • TABLE 21 ASIA-PACIFIC DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
        • TABLE 22 LATIN AMERICAN DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
        • TABLE 23 MENA DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
        • TABLE 24 CIS DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
      • Deafness and Hearing Loss Disorders
        • FIGURE 25 ESTIMATED PERCENTAGE INCREASE IN NUMBER OF PERSONS (65 YEARS AND OLDER) WITH HEARING LOSS BY REGION, 2010-2020 (%)
      • Kidney Diseases
      • Chronic Pulmonary Diseases
      • Increasing Life Expectancy Triggering Incidence Rates of Target Diseases
        • FIGURE 26 GLOBAL PERCENTAGE A PERSON'S SUSCEPTIBILITY TO CHRONIC DISEASES BY AGE GROUP, 2000 AND 2015 (%)
    • RESTRAINTS
      • Lack of Standardization for Testing, Stringent Regulations and Reimbursement Policies for MEMS-based Sensors
    • OPPORTUNITIES
      • Technological Advances in MEMS Technology
      • Implantable MEMS-Based Sensors
        • TABLE 25 IMPLANTABLE SENSORS
  • MARKET STRATEGIES
    • INCREASE INVESTMENTS IN R&D
      • Opportunities in Emerging Economies
      • High Investment Costs Associated with MEMS-Based Devices
    • COMPETITIVE LANDSCAPE
      • FIGURE 27 GLOBAL MARKET SHARE FOR DISPOSABLE MEDICAL SENSORS BY COMPANY, 2013* (%)
  • REGULATIONS
    • UNITED STATES
    • EUROPEAN UNION
    • CHINA
      • FIGURE 28 APPROVAL PROCESS OF CHINA SFDA REGULATORY BODY INVOLVED IN DISPOSABLE MEDICAL SENSORS
  • INNOVATIONS IN TECHNOLOGY
    • TATTOO SENSORS
    • PATCH SENSORS
    • SLEEP STRIPS
    • CANCER-TRACKING IMPLANTABLE SENSORS
    • DISPOSABLE HBA1C SENSORS
    • MEMS PRESSURE SENSORS
    • NANOELECTROMECHANICAL SYSTEMS (NEMS): A FUTURE TECHNOLOGY
    • INNOVATIVE DISPOSABLE SENSORS
  • CURRENT TRENDS
  • ADVANTAGE TO MANUFACTURERS OF DISPOSABLE WIRELESS SENSORS
  • DISPOSABLE MEDICAL SENSORS MARKET SET TO GROW

CHAPTER 6 - HEALTH SELF-MONITORING: TECHNOLOGIES AND GLOBAL MARKET (REPORT HLC185A)

  • INTRODUCTION
    • STUDY BACKGROUND
    • GOALS AND OBJECTIVES
    • INTENDED AUDIENCE
    • SCOPE AND FORMAT
    • METHODOLOGY
    • ANALYSTS' CREDENTIALS
    • RELATED BCC RESEARCH REPORTS
  • EXECUTIVE SUMMARY
    • TABLE 26 GLOBAL MARKET FOR SELECTED HEALTH SELF-MONITORING TECHNOLOGIES, THROUGH 2019 ($ MILLIONS)
    • FIGURE 29 GLOBAL MARKET FOR SELECTED HEALTH SELF-MONITORING TECHNOLOGIES, 2013-2019 ($ MILLIONS)
  • DEFINITIONS
    • DIGITAL VS. ANALOG MONITORING TECHNOLOGIES
    • MOBILE VS. PORTABLE MONITORING TECHNOLOGIES
    • SELF-TESTING VS. SELF-MONITORING
    • HEALTH VS. SPORTS AND FITNESS MONITORING
  • ENABLING TECHNOLOGIES
    • SMARTPHONES
    • ENHANCED DATA PROCESSING CAPABILITIES
    • SENSORS
      • MEMS Sensors
      • PFOE Sensors
    • GEOSPATIAL TRACKING
    • SMART TEXTILES FOR WEARABLE SENSORS
    • NETWORKING TECHNOLOGIES
      • Bluetooth
      • ANT+
      • ZigBee
      • Near-Field Communications
      • Human Area Networks
      • Cellular Communications
      • Wi-Fi
    • CLOUD SERVICES
  • MARKET SEGMENTS
    • TECHNOLOGIES
      • Platforms
      • Hubs
        • FIGURE 30 SELF-MONITORING HUB (SCHEMATIC)
      • Peripherals
      • Software
    • APPLICATIONS
      • Fitness, Wellness and Prevention
      • Fertility and Reproductive Health
      • Chronic Disease Management
      • Post-Acute Care and Rehabilitation
      • Aging at Home
      • Mental Health
    • PURCHASERS/PAYERS
      • Consumers
      • Employers
      • Hospitals/Healthcare Providers
      • Insurers
      • Private Insurers
      • Medicare and Medicaid
    • MARKET SUMMARY
      • FIGURE 31 GLOBAL MARKET FOR HEALTH SELF-MONITORING TECHNOLOGIES, 2013-2019 ($ MILLIONS)
      • TABLE 27 GLOBAL MARKET FOR HEALTH SELF-MONITORING TECHNOLOGIES BY TYPE OF TECHNOLOGY, THROUGH 2019 ($ MILLIONS)
      • FIGURE 32 GLOBAL MARKET FOR HEALTH SELF-MONITORING TECHNOLOGIES BY REGION, 2013-2019 ($ MILLIONS)

CHAPTER 7 - OPHTHALMIC DEVICES: TECHNOLOGIES AND GLOBAL MARKETS (REPORT HLC173A)

  • INTRODUCTION
    • STUDY GOALS AND OBJECTIVES
    • REASONS FOR DOING THE REPORT
    • SCOPE OF REPORT
    • INTENDED AUDIENCE
    • METHODOLOGY AND INFORMATION SOURCES
    • ANALYSTS' CREDENTIALS
    • RELATED BCC RESEARCH REPORTS
  • SUMMARY
    • TABLE 28 GLOBAL OPHTHALMIC DEVICE MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 33 GLOBAL OPHTHALMIC DEVICE MARKET BY REGION, 2013-2019 ($ MILLIONS)
  • INTRODUCTION TO THE HUMAN EYE
    • FIGURE 34 STRUCTURE OF THE EYE
  • EYE CONDITIONS AND THE ADDRESSABLE POPULATION
    • CATARACTS
      • Cataract Prevalence
        • FIGURE 35 PREVALENCE OF CATARACTS IN THE UNITED STATES, 2000-2050 (MILLIONS)
      • Cataract Treatment
    • GLAUCOMA
      • Prevalence of Glaucoma
        • FIGURE 36 PREVALENCE OF GLAUCOMA IN THE UNITED STATES, 2000-2050 (MILLIONS)
      • Treatment and Monitoring
      • New Surgical Glaucoma Treatments
    • DIABETIC RETINOPATHY
      • Prevalence of Diabetic Retinopathy
        • TABLE 29 PREVALENCE OF DIABETIC RETINOPATHY BY REGION (%)
      • Treatment and Monitoring
    • AGE-RELATED MACULAR DEGENERATION
      • Prevalence of AMD
        • FIGURE 37 PREVALENCE OF AGE-RELATED MACULAR DEGENERATION IN THE UNITED STATES, 2000-2050 (MILLIONS)
      • Diagnosis and Treatment of AMD
    • REFRACTIVE DISORDERS
      • Prevalence of Refractive Disorders
        • FIGURE 38 PREVALENCE OF MYOPIA AND HYPEROPIC IN THE UNITED STATES, 2000-2050 (MILLIONS)
      • Diagnosis and Treatment of Refractive Disorders

LIST OF TABLES

  • TABLE 1: MARKET FOR U.S. LABORATORY-DEVELOPED TESTS, THROUGH 2019 ($ MILLIONS)
  • TABLE 2: LIFE CYCLE OF CLINICAL DIAGNOSTIC TESTS
  • TABLE 3: RADIATION THERAPY MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 4: CHARACTERISTICS OF BENIGN AND MALIGNANT TUMORS
  • TABLE 5: IMPACT OF CANCER PROTECTIVE FACTORS AND CANCER RISK FACTORS ON VARIOUS TYPES OF CANCERS
  • TABLE 6: STEPS INVOLVED IN RADIATION THERAPY
  • TABLE 7: ADVANTAGES AND DISADVANTAGES OF VARIOUS CANCER TREATMENTS
  • TABLE 8: GLOBAL MARKET FOR MIS DEVICES AND EQUIPMENT, THROUGH 2019 ($ MILLIONS)
  • TABLE 9: SURGICAL PROCEDURES COMMONLY PERFORMED IN THE U.S. USING A MINIMALLY INVASIVE APPROACH, 2013
  • TABLE 10: PRINCIPAL TYPES OF MONITORING/VISUALIZATION EQUIPMENT
  • TABLE 11: PRINCIPAL TYPES OF SURGICAL ROBOTIC SYSTEMS
  • TABLE 12: ELECTROSURGICAL EQUIPMENT
  • TABLE 13: PRINCIPAL TYPES OF MECHANICAL INSTRUMENTS
  • TABLE 14: PRINCIPAL TYPES OF AUXILIARY EQUIPMENT USED FOR MINIMALLY INVASIVE SURGERY
  • TABLE 15: MINIMALLY INVASIVE SURGICAL DEVICES
  • TABLE 16: GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 17: EVOLUTION OF MEMS IN THE HEALTHCARE SECTOR
  • TABLE 18: CANCER INCIDENCES, 2008 AND 2015 (MILLIONS)
  • TABLE 19: NORTH AMERICA DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
  • TABLE 20: EUROPEAN DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
  • TABLE 21: ASIA-PACIFIC DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
  • TABLE 22: LATIN AMERICAN DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
  • TABLE 23: MENA DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
  • TABLE 24: CIS DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
  • TABLE 25: IMPLANTABLE SENSORS
  • TABLE 26: GLOBAL MARKET FOR SELECTED HEALTH SELF-MONITORING TECHNOLOGIES, THROUGH 2019 ($ MILLIONS)
  • TABLE 27: GLOBAL MARKET FOR HEALTH SELF-MONITORING TECHNOLOGIES BY TYPE OF TECHNOLOGY, THROUGH 2019 ($ MILLIONS)
  • TABLE 28: GLOBAL OPHTHALMIC DEVICE MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 29: PREVALENCE OF DIABETIC RETINOPATHY BY REGION (%)

LIST OF FIGURES

  • FIGURE 1: MARKET FOR U.S. LABORATORY-DEVELOPED TESTS, 2012-2019 ($ MILLIONS)
  • FIGURE 2: RADIATION THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • FIGURE 3: TYPES OF RADIATION
  • FIGURE 4: CELL GROWTH CYCLE
  • FIGURE 5: RADIATION THERAPY MARKET SEGMENTATION
  • FIGURE 6: DRIVERS, RESTRAINTS, OPPORTUNITIES AND TRENDS IN THE RADIATION THERAPY MARKET
  • FIGURE 7: GLOBAL AGING POPULATION (MILLIONS)
  • FIGURE 8: FACTORS RELATED TO AGING AND THE PROMOTION OF CANCER
  • FIGURE 9: MARKET SHARE ANALYSIS OF THE RADIATION THERAPY MARKET, 2013 (%)
  • FIGURE 10: GLOBAL MARKET FOR MIS DEVICES AND EQUIPMENT, 2013-2019 ($ MILLIONS)
  • FIGURE 11: MIS PROCEDURES AS A PERCENTAGE OF ALL SURGICAL PROCEDURES PERFORMED IN THE U.S., 2013 (%)
  • FIGURE 12: MIS PROCEDURES AS A PERCENTAGE OF SELECTED TYPES OF SURGICAL MEASURES IN THE U.S., 2013
  • FIGURE 13: SURGICAL PROCEDURES PERFORMED IN THE U.S. USING ALL MIS APPROACHES, 2013 (% OF ALL MIS PROCEDURES)
  • FIGURE 14: U.S. HOSPITALS WITH SURGERY DEPARTMENTS, 2013 (NUMBER OF HOSPITALS)
  • FIGURE 15: U.S. SURGICAL SPECIALTIES, 2013 (% OF ALL U.S. SURGEONS)
  • FIGURE 16: GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY REGION, 2013-2019 ($ MILLIONS)
  • FIGURE 17: TYPES OF SENSORS
  • FIGURE 18: SEGMENTATION OF BIOSENSORS
  • FIGURE 19: GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY PRODUCT, 2013 ($ MILLIONS)
  • FIGURE 20: GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY TYPE, 2013 ($ MILLIONS)
  • FIGURE 21: GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY APPLICATION, 2013 ($ MILLIONS)
  • FIGURE 22: GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY REGION, 2013-2019 ($ MILLIONS)
  • FIGURE 23: DIABETES PREVALENCE IN TOP 10 COUNTRIES FOR AGES 20 TO 79 YEARS, 2013 (MILLIONS)
  • FIGURE 24: GLOBAL DIABETES PREVALENCE BY REGION, 2013 AND 2035 (MILLIONS)
  • FIGURE 25: ESTIMATED PERCENTAGE INCREASE IN NUMBER OF PERSONS (65 YEARS AND OLDER) WITH HEARING LOSS BY REGION, 2010-2020 (%)
  • FIGURE 26: GLOBAL PERCENTAGE A PERSON'S SUSCEPTIBILITY TO CHRONIC DISEASES BY AGE GROUP, 2000 AND 2015 (%)
  • FIGURE 27: GLOBAL MARKET SHARE FOR DISPOSABLE MEDICAL SENSORS BY COMPANY, 2013* (%)
  • FIGURE 28: APPROVAL PROCESS OF CHINA SFDA REGULATORY BODY INVOLVED IN DISPOSABLE MEDICAL SENSORS
  • FIGURE 29: GLOBAL MARKET FOR SELECTED HEALTH SELF-MONITORING TECHNOLOGIES, 2013-2019 ($ MILLIONS)
  • FIGURE 30: SELF-MONITORING HUB (SCHEMATIC)
  • FIGURE 31: GLOBAL MARKET FOR HEALTH SELF-MONITORING TECHNOLOGIES, 2013-2019 ($ MILLIONS)
  • FIGURE 32: GLOBAL MARKET FOR HEALTH SELF-MONITORING TECHNOLOGIES BY REGION, 2013-2019 ($ MILLIONS)
  • FIGURE 33: GLOBAL OPHTHALMIC DEVICE MARKET BY REGION, 2013-2019 ($ MILLIONS)
  • FIGURE 34: STRUCTURE OF THE EYE
  • FIGURE 35: PREVALENCE OF CATARACTS IN THE UNITED STATES, 2000-2050 (MILLIONS)
  • FIGURE 36: PREVALENCE OF GLAUCOMA IN THE UNITED STATES, 2000-2050 (MILLIONS)
  • FIGURE 37: PREVALENCE OF AGE-RELATED MACULAR DEGENERATION IN THE UNITED STATES, 2000-2050 (MILLIONS)
  • FIGURE 38: PREVALENCE OF MYOPIA AND HYPEROPIC IN THE UNITED STATES, 2000-2050 (MILLIONS)
Back to Top